• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

52.02 -2.17 (-4.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,368,140
Open 53.26
Bid (Size) 52.00 (100)
Ask (Size) 52.10 (100)
Prev. Close 54.19
Today's Range 51.85 - 53.59
52wk Range 36.08 - 78.48
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking ↗
June 01, 2026
This little-discussed pipeline program could prove to be a big success. 
Via The Motley Fool
News headline image
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026? ↗
May 31, 2026
One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk profiles stack up for 2026. 
Via The Motley Fool

Performance

YTD
-3.3%
-3.3%
1 Month
-2.9%
-2.9%
3 Month
-14.4%
-14.4%
6 Month
-0.3%
-0.3%
1 Year
+40.8%
+40.8%

More News

Read More
News headline image
Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics? ↗
May 25, 2026
Via The Motley Fool
News headline image
The Best Stocks to Invest $3,000 In Right Now ↗
May 19, 2026
Via The Motley Fool
News headline image
CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms ↗
May 15, 2026
Via MarketBeat
Topics Intellectual Property
News headline image
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist? ↗
May 11, 2026
Via The Motley Fool
News headline image
Is This Millionaire-Maker Biotech Stock a Buy Right Now? ↗
May 06, 2026
Via The Motley Fool
Topics Initial Public Offering
News headline image
Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering ↗
April 30, 2026
Via The Motley Fool
News headline image
What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer. ↗
April 30, 2026
Via The Motley Fool
News headline image
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead? ↗
April 30, 2026
Via The Motley Fool
News headline image
3 Growth Stocks That Could Generate 10X Returns ↗
April 29, 2026
Via The Motley Fool
Topics Cannabis Law Enforcement
News headline image
3 Biotech Stocks That Could Benefit from the Patent Cliff ↗
April 27, 2026
Via MarketBeat
Topics Intellectual Property
News headline image
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? ↗
April 21, 2026
Via The Motley Fool
News headline image
2 Billion Reasons to Love CRISPR Therapeutics Right Now ↗
April 13, 2026
Via The Motley Fool
News headline image
This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area ↗
April 08, 2026
Via The Motley Fool
News headline image
Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position? ↗
April 07, 2026
Via The Motley Fool
Topics ETFs
News headline image
CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now? ↗
March 23, 2026
Via The Motley Fool
News headline image
Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026
March 20, 2026
Via Finterra
Topics Intellectual Property
News headline image
Is CRISPR Therapeutics Stock a Buy Now? ↗
March 20, 2026
Via The Motley Fool
News headline image
3 Monster Stocks to Hold for the Next 10 Years ↗
March 10, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday ↗
March 10, 2026
Via The Motley Fool
News headline image
Why Is CRSP Stock Falling Pre-Market Today? ↗
March 10, 2026
Via Stocktwits
News headline image
RIVN Stock Gains 4% Pre-Market After TD Cowen Upgrade: Analyst Sees Strong Demand For Upcoming R2 Models ↗
March 10, 2026
Via Stocktwits
Topics Electric Vehicles
News headline image
Forget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of ↗
March 04, 2026
Via The Motley Fool
News headline image
Is CRISPR Therapeutics Stock Too Risky to Buy Right Now? ↗
March 02, 2026
Via The Motley Fool

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 52.02
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 06/02/26 04:00 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.11B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap